GSK Plc (GSK)
48.13
+0.01
(+0.02%)
USD |
NYSE |
Sep 11, 16:00
49.50
+1.37
(+2.85%)
Pre-Market: 05:07
GSK Market Cap : 97.35B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 97.35B |
| September 10, 2026 | 97.33B |
| September 09, 2026 | 98.36B |
| September 08, 2026 | 98.18B |
| September 04, 2026 | 100.91B |
| September 03, 2026 | 102.89B |
| September 02, 2026 | 102.02B |
| September 01, 2026 | 102.47B |
| August 31, 2026 | 101.64B |
| August 28, 2026 | 102.79B |
| August 27, 2026 | 101.68B |
| August 26, 2026 | 104.03B |
| August 25, 2026 | 105.32B |
| August 24, 2026 | 104.74B |
| August 21, 2026 | 106.01B |
| August 20, 2026 | 105.10B |
| August 19, 2026 | 106.96B |
| August 18, 2026 | 103.46B |
| August 17, 2026 | 101.70B |
| August 14, 2026 | 100.16B |
| August 13, 2026 | 102.05B |
| August 12, 2026 | 101.74B |
| August 11, 2026 | 102.96B |
| August 10, 2026 | 105.50B |
| August 07, 2026 | 107.12B |
| Date | Value |
|---|---|
| August 06, 2026 | 105.52B |
| August 05, 2026 | 104.09B |
| August 04, 2026 | 104.23B |
| August 03, 2026 | 104.19B |
| July 31, 2026 | 104.55B |
| July 30, 2026 | 105.32B |
| July 29, 2026 | 107.65B |
| July 28, 2026 | 108.64B |
| July 27, 2026 | 105.14B |
| July 24, 2026 | 103.87B |
| July 23, 2026 | 102.63B |
| July 22, 2026 | 102.67B |
| July 21, 2026 | 102.71B |
| July 20, 2026 | 101.22B |
| July 17, 2026 | 104.69B |
| July 16, 2026 | 106.74B |
| July 15, 2026 | 104.07B |
| July 14, 2026 | 103.66B |
| July 13, 2026 | 105.77B |
| July 10, 2026 | 106.76B |
| July 09, 2026 | 106.13B |
| July 08, 2026 | 106.23B |
| July 07, 2026 | 107.85B |
| July 06, 2026 | 107.39B |
| July 02, 2026 | 108.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 496.79B |
| Eli Lilly & Co. | 1.050T |
| Merck & Co., Inc. | 355.31B |
| Novo Nordisk A/S | 144.11B |
| Novartis AG | 251.08B |
Market Cap Related Metrics
| PE Ratio | 15.16 |
| PS Ratio | 2.204 |
| PEG Ratio | 0.3162 |
| Price to Book Value | 4.157 |
| Price to Free Cash Flow | 14.83 |
| Price | 48.13 |
| Earnings Yield | 6.59% |
| PEGY Ratio | 0.293 |
| Operating PE Ratio | 8.817 |
| Normalized PE Ratio | 10.44 |